Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Curve type (GR values) Curve type (relative cell counts) Experiment name Number of concentrations Cell doublings (DMSO control) GR50 GRmax GR_AOC GEC50 GRinf Hill slope (GR values) R-squared sigmoid fit (GR values) P-value sigmoid fit (GR values) R-squared flat fit (GR values) IC50 Emax AUC EC50 Einf Hill slope (relative cell counts) R-squared sigmoid fit (relative cell counts) P-value sigmoid fit (relative cell counts) R-squared flat fit (relative cell counts)
Hs 578T WYE-125132 3
sigmoid
sigmoid
Hs578T WYE-132 3
8 2.876
0.0568
0.189
0.452
0.0346
0.192
0.975
0.996
7.69e-08
NA
0.0403
0.224
0.522
0.0221
0.221
0.97
0.993
4.12e-07
NA
Hs 578T XL147 1
flat
flat
Hs578T pilaralisib 1
8 2.013
Inf
0.967
0.00411
0.0
0.967
0.01
0.193
0.525
0.991
Inf
0.967
0.996
0.0
0.967
0.01
0.196
0.519
0.991
Hs 578T XL147 2
flat
flat
Hs578T pilaralisib 2
8 2.509
Inf
0.976
0.000255
0.0
0.976
0.01
0.435
0.181
0.997
Inf
0.97
1.0
0.0
0.97
0.01
0.432
0.183
0.996
Hs 578T XL147 3
flat
flat
Hs578T pilaralisib 3
8 2.879
Inf
0.971
-0.00618
0.0
0.971
0.01
0.331
0.299
1.0
Inf
0.959
1.01
0.0
0.959
0.01
0.319
0.315
1.0
Hs 578T ZSTK474 1
sigmoid
sigmoid
Hs578T ZSTK474 1
8 1.968
0.325
0.137
0.279
0.265
0.0807
0.854
0.973
1.94e-05
NA
0.471
0.329
0.764
0.149
0.343
1.01
0.972
2.27e-05
NA
Hs 578T ZSTK474 2
sigmoid
sigmoid
Hs578T ZSTK474 2
8 2.554
0.715
0.187
0.263
5.92
-0.896
0.485
0.995
1.27e-07
NA
0.583
0.264
0.722
0.583
0.0
0.56
0.993
3.28e-07
NA
Hs 578T ZSTK474 3
sigmoid
sigmoid
Hs578T ZSTK474 3
8 2.863
0.913
0.31
0.201
0.613
0.143
0.846
0.999
6.21e-10
NA
0.607
0.298
0.767
0.329
0.211
0.895
0.999
1.43e-09
NA